Kathleen Richton
Senior VP of Finance, Principal Accounting & Financial Officer and ControllerMs. Kathleen Richton serves as Senior Vice President of Finance and Principal Accounting & Financial Officer at enGene Therapeutics Inc. since July 16, 2026 and serves as its Controller since March 2026. He served as Vice President of enGene Therapeutics Inc. since March 2026 and served as its Executive Director of Finance from January 2025 to March 2026. Prior to joining the Company, Ms. Richton served as Vice President, Controller at Sumitomo Pharma America from September 2020 to July 2023. Ms. Richton spent over 15 years at Sunovion Pharmaceuticals, where she held positions of increasing responsibility within the finance organization, serving as Executive Director, Corporate Financial Planning & Strategic Analysis from 2017 to 2020. Ms. Richton holds a B.Sc. in Accountancy and a M.S. in Accounting Information Systems from Bentley University and is a Certified Public Accountant in Massachusetts.
Positions
- Company NameenGene Therapeutics Inc.Stock CodeENGNPositionSenior VP of Finance, Principal Accounting & Financial Officer and ControllerRelated SecuritiesColleagues
- RHRonald H. W. CooperPresident, CEO & Director
- MTMichael Thomas HeffernanIndependent Non-Executive Chairman
- JCJoan ConnollyChief Technology Officer
- JGJason G. DuncanChief Legal & Administrative Officer
- LSLauren Stival HopferExecutive Director of Investor Relations
- PDPaul D. RobbinsChairman of Scientific Advisory Board
- LSLota S. ZothIndependent Non-Executive Director
- WSWouter Sebastian Johannes JoustraIndependent Non-Executive Director
